Eli Lilly

The FDA recently approved higher-dose version of Novo Nordisk’s NVO obesity drug Wegovy, further expanding the drug giant’s footprint in…

A drug that helped turn Novo Nordisk into Europe’s most valuable company is about to lose its…

Federal regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy that may help…

Many of the top companies successfully cashing in on artificial intelligence (AI) are in the technology sector. However,…

March 2 (Reuters) – Eli Lilly CFO ‌Lucas Montarce said ‌on Monday it is preparing to launch its…

Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) are locked in a battle around GLP-1 weight-loss drugs.…

Wednesday 18 February 2026 2:27 pm | Updated: Wednesday 18 February 2026 3:10 pm Share Facebook Share on Facebook…

JPMorgan Chase just planted a massive $2.93 billion flag in perhaps one of the hottest corners of the…

Novo Nordisk plans Wegovy vials amid obesity-drug competition Proactive uses images sourced from Shutterstock Novo Nordisk (NYSE:NVO) announced…

Super Bowl Sunday is the holy grail of advertising thanks to its massive viewership, with an average of…

Feb 5 (Reuters) – Hims & Hers said it would begin offering compounded versions of Novo Nordisk’s Wegovy…

Eli Lilly’s (NYSE: LLY) share price jumped 39% in 2025, driven by investors eager to benefit from the…

Diversify With These Health ETFs